
Indication
Lowering IOP in chronic open-angle glaucoma or ocular hypertension

Mechanism of Action
Betaxolol is a beta-1 cardioselective beta-blocker that reduces intraocular pressure by decreasing aqueous humor production. This reduction is thought to be achieved through the inhibition of beta-adrenergic receptors in the eye, leading to decreased formation and secretion of aqueous humor.

Available Quantities
2.5 ml, 5 ml, 10 ml, 15 ml

Dosage/Instructions
0.25%: 1 or 2 drops twice daily (bid)

Pregnancy & Nursing
Use cautiously during pregnancy. No adequate and well-controlled studies in pregnant women.

Pediatric Use
≥1 week

Contraindications, side effects, etc.
Contraindicated in hypersensitivity, sinus bradycardia, AV block, cardiac failure, cardiogenic shock. Warnings include systemic absorption, cardiac failure, diabetes mellitus, thyrotoxicosis, muscle weakness, surgical anesthesia, bronchospasm, obstructive pulmonary disease, atopy/anaphylaxis, angle-closure glaucoma, vascular insufficiency, bacterial keratitis, choroidal detachment, contact lens wear. Adverse reactions: ocular discomfort, blurred vision, corneal punctate keratitis, foreign body sensation, photophobia, tearing, itching, dry eyes, erythema, inflammation, discharge, ocular pain, decreased visual acuity, crusty lashes, systemic reactions like bradycardia, heart block, congestive failure, pulmonary distress, insomnia, dizziness, vertigo, headaches, depression, lethargy, myasthenia gravis symptoms, hives, toxic epidermal necrolysis, hair loss, glossitis, taste and smell perversions.